AstraZeneca Rises Almost 9% in a Month: How to Play the Stock
AZNs key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales in 2025.…
76,500€
-1,29%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
FTSE 100 dips as heavyweight ex-dividends drag, Lloyds soars
The FTSE 100 dropped again on Thursday as companies accounting for a significant proportion of the index traded ex-dividend and…
4 AI Stocks to Watch in the Quantum Computing Revolution
Following the stock markets record-breaking 2024, during which the S&P 500 index returned a spectacular 23%, theres optimism among investors…
Directorate Change
18 February 2025
Non-Executive Board Changes
AstraZeneca PLC announced today that Karen Knudsen will be proposed for election as a Non-Executive Director…
AZN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that AstraZeneca PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally…